Facts and Figures

Learn more about what makes the Icahn School of Medicine at Mount Sinai (ISMMS) a leader. Review data and background information about the School and our faculty, staff, and students. You can also find information on admissions, research, clinical care, and our partnerships and academic affiliations.

Who We Are

At ISMMS we train the physicians and scientists of tomorrow while we conduct breakthrough research and provide multidisciplinary clinical care.

Quick Facts

Academic Community

  • 556 medical students
  • 92 MD/PhD students
  • 283 PhD students
  • 300 master’s degree students
  • 600+ Postdoctoral Fellows

NIH Funding

  • $267.3 million in National Institutes of Health (NIH) funding awarded to our researchers in 2015
  • 15th among U.S. medical schools for NIH funding
  • 2nd in research dollars per principal investigator among U.S. medical schools by the Association of American Medical Colleges (AAMC)

*As of 2016

Since it opened in 1968, the School, led by Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President for Academic Affairs, Mount Sinai Health System, has become a world-class leader in medical education, research, and patient care.

  • The School is made up of 29 multidisciplinary research, educational, and clinical Institutes and 34 academic Departments
  • Annual budget: $1.9 billion
  • Named 4th among “World’s Most Innovative Companies in Data Science” by Fast Company magazine in 2016
  • More than 5,900 full-time, part-time, and voluntary faculty
  • 4,124 people employed full-time by the School (excluding faculty)

Our students come from diverse backgrounds and engage in a wide variety of studies through our Medical Education Program and our Graduate School of Biomedical Sciences.  For the 2015-2016 academic year:

  • 1,231 students enrolled in MD, PhD, MD/PhD, and master’s degree programs
    • 556 medical students
    • 92 MD/PhD students
    • 283 PhD students
    • 300 master’s degree students
  • More than 2,000 residents and fellows
  • More than 600 postdoctoral candidates received progressive training
  • 90 student groups and organizations recognized by the Mount Sinai Student Council
  • Students graduating with dual degrees
    • 56 dual MD/PhD graduates
    • 22 dual MD/MPH graduates
  • A diverse pool of students
    • MD Students:
      • Women: 48 percent
      • Underrepresented minorities: 17.4 percent
      • Age range: 20 to 41
    • Graduate Students:
      • Women: 58 percent
      • Underrepresented minorities: 15.8 percent
      • Age range: 21 to 59

We are a highly selective school, attracting leading applicants from around the world and selecting those who not only have the strongest academic credentials but who are committed to science in service to society. For the 2015-2016 academic year:

  • 6,165 applications received
    • 5,092 MD and MD/PhD applications
    • 1,073 graduate program applications
  • More than 1,000 interviews conducted
    • 825 MD and MD/PhD
    • 178 graduate programs
  • 947 applicants accepted
    • 467 MD and MD/PhD
    • 480 graduate programs
  • Most popular undergraduate majors for accepted students included biological science, biomedical engineering, chemistry, history, human biology, molecular and cellular biology, neuroscience, psychology
  • Average age for entering medical students: 23
  • Average age for entering graduate students: 27
  • GPA and MCAT scores for admitted MD and MD/PhD candidates
    • Matriculated Median UGPA: 3.78
    • Matriculated Median MCAT: 36
  • GPA and GRE scores for admitted graduate students
    • Matriculated Median UGPA: 3.5
    • Matriculated Median GRE Verbal: 159
    • Matriculated Median GRE Quant: 159
    • Matriculated Median GRE Writing: 4

Our investigators conduct groundbreaking research with funding support that moves discoveries from the bench to the bedside and from the lab to the marketplace.

  • $267.3 million in National Institutes of Health (NIH) funding awarded to our researchers in 2015
    • Ranked 15th among U.S. medical schools for NIH funding
    • Ranked 2nd in research dollars per principal investigator among U.S. medical schools by the Association of American Medical Colleges (AAMC)
  • Mount Sinai Innovation Partners helps bring many discoveries to market
    • 17 marketed products and technologies including FluMist vaccine, Fabrazyme®, a treatment for Fabry disease, and the Annuloplasty Ring, a device for repairing heart valves
    • 12 products currently in the development

Patients have access to care by physicians with expertise across a wide range of specialties in The Mount Sinai Health System’s network throughout the five boroughs and Long Island. Here are some facts from 2014:

  • Nearly 1,200 physicians saw patients through our Mount Sinai Doctors Faculty Practice, a multi-specialty group practice, which is expected to grow to 2,000 by 2016
  • 125 specialties within 27 clinical departments
  • 991,000 annual physician visits to Mount Sinai Doctors Faculty Practice
  • 129 physicians named to New York Magazine’s “Best Doctors” issue

History of Innovation at the Icahn School of Medicine at Mount Sinai